APPLICATIONS PUBLISHED 25 JUNE 2003

Published: 1-Dec-2003

The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492


The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. T +43 1521 260 F +43 1 52126 4492

  • Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
    Chiron 1320355*

  • Preparation of vitamin emulsions and concentrates thereof
    Nycomed Pharma 1320356*

  • Topical polymeric antimicrobial emulsion
    Chemeq 1320357*

  • Topical formulations for delivery of interleukin-11
    Genetics Institute 1320358*

  • Thermogelling biodegradable aqueous polymer solution
    Battelle Memorial Institute 1320359*

  • Methods and compsns for the treatment and prevention of sexual dysfunction
    Sepracor 1320360*

  • Method for reducing exacerbations associated with COPD
    SmithKline Beecham 1320361*

  • Stabilised fibrate microparticles
    RTP Pharma 1320362*

  • Lactone integrin antagonists
    Pharmacia 1320363*

  • The use of histamine H3-receptor inverse agonists for the control of appetite and treatment of obesity
    Gliatech 1320364*

  • Substituted azole derivatives as inhibitors of corticotropin releasing factor
    Bristol-Myers Squibb 1320365*

  • Substituted piperidines as melanocortin receptor agonists
    Merck 1320366*

  • Process for the preparation of dinapsoline
    Purdue Research Foundation 1320367*

  • Infusion of ciprofloxacin having reduced acid content and being stable in storage
    Fresenius Kabi Deutschland 1320368*

  • A method of analgesia
    Wex Medical 1320369*

  • Method of treatment
    SmithKline Beecham 1320370*

  • Charged phospholipid compsns and methods for their use
    Ottawa Heart Institute Research 1320371*

  • Pharmaceutical preparation and method for the treatment of diabetes
    A+ Science 1320372*

  • Treatment of arthritis and compsns therefore
    Anastassiades, Tassos 1320373*

  • Influenza virus binding, sialylated oligosaccharide substance and use thereof
    Biotie Therapies 1320374*

  • Inhibition of systemic infections in humans and vertebrates by dietary fibres
    Mississippi State University; Tiense Suikerraffinaderij 1320375*

  • Treatment of prostate cancer
    Peplin Research 1320376*

  • HLA binding peptides and their uses
    Epimmune 1320377*

  • Improved protocol for paracentesis
    Institut National de la Sante et de la Recherche Medicale 1320378*

  • Use of replication-deficient poxvirus vector to boost CD4+ T cell immune response to antigen
    Oxxon Pharmaccines 1320379*

  • Tubulin based vaccine against trypanosomiasis
    McGill University 1320380*

  • New immunogenic complex
    Isconova 1320381*

  • Novel methods for inhibition of viral infection
    The Regents of the University of Michigan 1320382*

  • Photosensitisers
    The University of Leeds 1320383*

  • The synergistic effects of HGF and antibacterial treatment
    Nayeri, Fariba 1320384*

  • Combination compsns
    Ashmont Holdings 1320385*

  • A novel cationic lipopolymer as biocompatible gene delivery agent
    Expression Genetics 1320386*

  • Pharmaceutical compsns for sustained drug delivery
    Praecis Pharmaceuticals 1320387*

  • Concept for slurry separation and biogas production
    Green Farm Energy 1320388*

  • You may also like